Non-contrast magnetic resonance imaging for bladder cancer: fused high b value diffusion-weighted imaging and T2-weighted imaging helps evaluate depth of invasion

European Radiology

Volumn 27, Issue 9, 2017, Pages 3752-3758

  Lee, Minsu ^a   Shin, Su Jin ^a,b   Oh, Young Taik ^a   Jung, Dae Chul ^a   Cho, Nam Hoon ^a   Choi, Young Deuk ^a   Park, Sung Yoon ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Hanyang University College of Medicine   (South Korea)

Author keywords

Bladder cancer; Diffusion weighted imaging; Fusion; MRI; Stage

Indexed keywords

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BLADDER CANCER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFUSION WEIGHTED IMAGING; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PREDICTIVE VALUE; PRIORITY JOURNAL; RADIOLOGIST; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; T2 WEIGHTED IMAGING; TRANSITIONAL CELL CARCINOMA; TUMOR INVASION; BLADDER TUMOR; CARCINOMA; DIAGNOSTIC IMAGING; MIDDLE AGED; PATHOLOGY; PROCEDURES; RETROSPECTIVE STUDY; STANDARDS; URETHRA TUMOR; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AREA UNDER CURVE; CARCINOMA; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; URETHRAL NEOPLASMS; URINARY BLADDER NEOPLASMS;

EID: 85011684793     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-017-4759-2     Document Type: Article

References (18)

1. Babjuk M, Bohle A, Burger M et al (2016) EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016. Eur Urol. doi:10.1016/j.eururo.2016.05.041
2. World Health Organization Consensus Conference on Bladder Cancer, Hautmann RE, Abol-Enein H et al (2007) Urinary diversion. Urology 69:17–49
3. Matsuki M, Inada Y, Tatsugami F, Tanikake M, Narabayashi I, Katsuoka Y (2007) Diffusion-weighted MR imaging for urinary bladder carcinoma: initial results. Eur Radiol 17:201–204
4. Abou-El-Ghar ME, El-Assmy A, Refaie HF, El-Diasty T (2009) Bladder cancer: diagnosis with diffusion-weighted MR imaging in patients with gross hematuria. Radiology 251:415–421
5. El-Assmy A, Abou-El-Ghar ME, Mosbah A et al (2009) Bladder tumour staging: comparison of diffusion- and T2-weighted MR imaging. Eur Radiol 19:1575–1581
6. Takeuchi M, Sasaki S, Ito M et al (2009) Urinary bladder cancer: diffusion-weighted MR imaging–accuracy for diagnosing T stage and estimating histologic grade. Radiology 251:112–121
7. Kobayashi S, Koga F, Yoshida S et al (2011) Diagnostic performance of diffusion-weighted magnetic resonance imaging in bladder cancer: potential utility of apparent diffusion coefficient values as a biomarker to predict clinical aggressiveness. Eur Radiol 21:2178–2186
8. El-Assmy A, Abou-El-Ghar ME, Refaie HF, Mosbah A, El-Diasty T (2012) Diffusion-weighted magnetic resonance imaging in follow-up of superficial urinary bladder carcinoma after transurethral resection: initial experience. BJU Int 110:E622–E627
9. Takeuchi M, Sasaki S, Naiki T et al (2013) MR imaging of urinary bladder cancer for T-staging: a review and a pictorial essay of diffusion-weighted imaging. J Magn Reson Imaging 38:1299–1309
10. Wu LM, Chen XX, Xu JR et al (2013) Clinical value of T2-weighted imaging combined with diffusion-weighted imaging in preoperative T staging of urinary bladder cancer: a large-scale, multiobserver prospective study on 3.0-T MRI. Acad Radiol 20:939–946
11. Ohgiya Y, Suyama J, Sai S et al (2014) Preoperative T staging of urinary bladder cancer: efficacy of stalk detection and diagnostic performance of diffusion-weighted imaging at 3T. Magn Reson Med Sci 13:175–181
12. Zhou G, Chen X, Zhang J, Zhu J, Zong G, Wang Z (2014) Contrast-enhanced dynamic and diffusion-weighted MR imaging at 3.0T to assess aggressiveness of bladder cancer. Eur J Radiol 83:2013–2018
13. Park JJ, Kim CK, Park SY, Park BK (2015) Parametrial invasion in cervical cancer: fused T2-weighted imaging and high-b-value diffusion-weighted imaging with background body signal suppression at 3 T. Radiology 274:734–741
14. Lin G, Ng KK, Chang CJ et al (2009) Myometrial invasion in endometrial cancer: diagnostic accuracy of diffusion-weighted 3.0-T MR imaging--initial experience. Radiology 250:784–792
15. Edge SBBD, Compton CC, Fritz AG, Greene FL, Trotti A (eds) (2010) AJCC cancer staging manual (7th ed). Springer, New York
16. Verma S, Rajesh A, Prasad SR et al (2012) Urinary bladder cancer: role of MR imaging. Radiographics 32:371–387
17. Yoshida S, Koga F, Kawakami S et al (2010) Initial experience of diffusion-weighted magnetic resonance imaging to assess therapeutic response to induction chemoradiotherapy against muscle-invasive bladder cancer. Urology 75:387–391
18. Yoshida S, Koga F, Kobayashi S et al (2012) Role of diffusion-weighted magnetic resonance imaging in predicting sensitivity to chemoradiotherapy in muscle-invasive bladder cancer. Int J Radiat Oncol Biol Phys 83:e21–e27